RESUMO
OBJECTIVE: Due to the global increase in obesity rates and success of bariatric surgery in weight reduction, an increasing number of women now present pregnant with a previous bariatric procedure. This study investigates the extent of bariatric-associated metabolic and gut microbial alterations during pregnancy and their impact on fetal development. DESIGN: A parallel metabonomic (molecular phenotyping based on proton nuclear magnetic resonance spectroscopy) and gut bacterial (16S ribosomal RNA gene amplicon sequencing) profiling approach was used to determine maternal longitudinal phenotypes associated with malabsorptive/mixed (n=25) or restrictive (n=16) procedures, compared with women with similar early pregnancy body mass index but without bariatric surgery (n=70). Metabolic profiles of offspring at birth were also analysed. RESULTS: Previous malabsorptive, but not restrictive, procedures induced significant changes in maternal metabolic pathways involving branched-chain and aromatic amino acids with decreased circulation of leucine, isoleucine and isobutyrate, increased excretion of microbial-associated metabolites of protein putrefaction (phenylacetlyglutamine, p-cresol sulfate, indoxyl sulfate and p-hydroxyphenylacetate), and a shift in the gut microbiota. The urinary concentration of phenylacetylglutamine was significantly elevated in malabsorptive patients relative to controls (p=0.001) and was also elevated in urine of neonates born from these mothers (p=0.021). Furthermore, the maternal metabolic changes induced by malabsorptive surgery were associated with reduced maternal insulin resistance and fetal/birth weight. CONCLUSION: Metabolism is altered in pregnant women with a previous malabsorptive bariatric surgery. These alterations may be beneficial for maternal outcomes, but the effect of elevated levels of phenolic and indolic compounds on fetal and infant health should be investigated further.
Assuntos
Aminoácidos/sangue , Peso ao Nascer , Derivação Gástrica , Gastroplastia , Glutamina/análogos & derivados , Gravidez , Ácido 3-Hidroxibutírico/sangue , Adulto , Índice de Massa Corporal , Clostridiales/isolamento & purificação , Creatinina/urina , Cresóis/urina , Enterococcus/isolamento & purificação , Escherichia/isolamento & purificação , Fezes/microbiologia , Feminino , Desenvolvimento Fetal , Microbioma Gastrointestinal , Glutamina/sangue , Glutamina/urina , Hemiterpenos/urina , Humanos , Indicã/urina , Recém-Nascido/urina , Resistência à Insulina , Isobutiratos/sangue , Isoleucina/sangue , Cetoácidos/urina , Leucina/sangue , Metabolômica , Micrococcaceae/isolamento & purificação , Fenótipo , Fenilacetatos/urina , Gravidez/sangue , Gravidez/urina , Streptococcus/isolamento & purificação , Ésteres do Ácido Sulfúrico/urina , Adulto JovemRESUMO
The metabolic mechanisms underlying aristolochic acid (AA)-induced nephrotoxicity are inconclusive. A Gas Chromatography-Mass Spectrometer (GC-MS)-based metabolomic study was performed to analyze urinary metabolites in AA-treated rats at different dosages (10, 20, and 40 mg/kg) and time points (2, 4, and 6 days). Serum blood urea nitrogen (BUN), creatinine, and kidney injury were significantly changed only on the 6th day in 40 mg/kg AA group, whereas metabolic alternation appeared even on the 2nd day in 10 mg/kg AA group. A total of 84 differential metabolites were identified in 40 mg/kg AA groups time-dependently and 81 in 10, 20, and 40 mg/kg AA groups dose-dependently (6 days) compared with control group. Eight metabolites were selected as potential metabolic biomarkers including methylsuccinic acid, nicotinamide, 3-hydroxyphenylacetic acid, citric acid, creatinine, uric acid, glycolic acid, and gluconic acid. Four of them were dose-dependently altered including methylsuccinic acid, citric acid, creatinine, and 3-hydroxyphenylacetic acid, which were defined as "early metabolic biomarker." The alteration of nicotinamide, uric acid, and gluconic acid was time- and dose-dependent, whereas the change of glycolic acid was time- or dose-independent. The latter 4 metabolites were defined as "late metabolic biomarker" because of the obvious reduction on the 6th day in 40 mg/kg AA group. In summary, the urinary metabolic alterations were more sensitive than conventional biomarkers of renal injury. The identified metabolites suggested pathways of energy metabolism, gut microbiota, and purine metabolism were associated with AA-induced nephrotoxicity time- or dose-dependently. Further investigation was warranted to determine the roles of the 8 potential metabolic biomarkers in AA-induced nephrotoxicity.
Assuntos
Ácidos Aristolóquicos/toxicidade , Carcinógenos/toxicidade , Rim/efeitos dos fármacos , Insuficiência Renal/induzido quimicamente , Animais , Ácidos Aristolóquicos/administração & dosagem , Biomarcadores/urina , Carcinógenos/administração & dosagem , Ácido Cítrico/urina , Creatinina/urina , Relação Dose-Resposta a Droga , Injeções Intraperitoneais , Rim/metabolismo , Rim/patologia , Rim/fisiopatologia , Masculino , Metabolômica/métodos , Fenilacetatos/urina , Análise de Componente Principal , Distribuição Aleatória , Ratos Wistar , Insuficiência Renal/metabolismo , Insuficiência Renal/patologia , Insuficiência Renal/fisiopatologia , Organismos Livres de Patógenos Específicos , Succinatos/urina , Toxicocinética , Aumento de Peso/efeitos dos fármacosRESUMO
Este estudo investiga as práticas de produção de conhecimento sobre a menopausa no Caism/Unicamp, centro de referência para políticas públicas em saúde da mulher. Foram realizadas observações de consultas ginecológicas, entrevistas com mulheres e médicos e observação de reuniões de apoio psicológico, buscando identificar os discursos que circulam no lugar e o processo de alistamento de diferentes atores para que os conhecimentos ali produzidos alcancem credibilidade e “viajem” além dos limites do hospital-escola, tornando-se “universais”. A análise baseia-se nos “estudos localistas”, alinhados aos estudos sociais de ciência e tecnologia.
This study investigates the practices involved in the production of knowledge about menopause at Caism, Unicamp, a reference center for public policies for women’s health. Gynecological appointments and psychological support meetings were observed, and women and doctors were interviewed in order to identify what discourse circulates there and how different actors are brought in to ensure that the knowledge produced attains credibility and “travels” beyond the boundaries of the teaching hospital to become “universal”. The analysis is based on localized studies aligned with social studies of science and technology.
Assuntos
Animais , Masculino , Camundongos , /genética , Complexo Principal de Histocompatibilidade , Odorantes , Ácido Benzoico , Benzoatos/isolamento & purificação , Benzoatos/urina , Butiratos/isolamento & purificação , Butiratos/urina , Cromatografia Gasosa , Cromatografia por Troca Iônica , Cresóis/isolamento & purificação , Cresóis/urina , Dimetil Sulfóxido , Discriminação Psicológica , Aprendizagem em Labirinto , Camundongos Endogâmicos , Fenóis/isolamento & purificação , Fenóis/urina , Fenilacetatos/isolamento & purificação , Fenilacetatos/urina , Sulfonas/isolamento & purificação , Sulfonas/urina , UltrafiltraçãoRESUMO
BACKGROUND: Mass screening for gastric cancer (GC), particularly using endoscopy, may not be the most practical approach as a result of its high cost, lack of acceptance, and poor availability. Thus, novel markers that can be used in cost-effective diagnosis and noninvasive screening for GC are needed. METHODS: A total of 154 urine samples from GC patients and healthy individuals and 30 pairs of matched tumor and normal stomach tissues were collected. Multivariate analysis was performed on urinary and tissue metabolic profiles acquired using (1)H nuclear magnetic resonance and (1)H high-resolution magic angle spinning spectroscopy, respectively. In addition, metabolic profiling of urine from GC patients after curative surgery was performed. RESULTS: Multivariate statistical analysis showed significant separation in the urinary and tissue data of GC patients and healthy individuals. The metabolites altered in the urine of GC patients were related to amino acid and lipid metabolism, consistent with changes in GC tissue. In the external validation, the presence of GC (early or advanced) from the urine model was predicted with high accuracy, which showed much higher sensitivity than carbohydrate antigen 19-9 and carcinoembryonic antigen. Furthermore, 4-hydroxyphenylacetate, alanine, phenylacetylglycine, mannitol, glycolate, and arginine levels were significantly correlated with cancer T stage and, together with hypoxanthine level, showed a recovery tendency toward healthy controls in the postoperative samples compared to the preoperative samples. CONCLUSIONS: An urinary metabolomics approach may be useful for the effective diagnosis of GC.
Assuntos
Biomarcadores Tumorais/urina , Espectroscopia de Ressonância Magnética , Metaboloma , Neoplasias Gástricas/patologia , Neoplasias Gástricas/urina , Alanina/urina , Área Sob a Curva , Arginina/urina , Biomarcadores Tumorais/sangue , Antígeno CA-19-9/sangue , Antígeno Carcinoembrionário/sangue , Estudos de Casos e Controles , Glicina/análogos & derivados , Glicina/urina , Glicolatos/urina , Humanos , Hipoxantina/urina , Manitol/urina , Metabolômica , Estadiamento de Neoplasias , Fenilacetatos/urina , Curva ROC , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/cirurgia , Resultado do Tratamento , Urinálise/métodosRESUMO
Cell differentiation agent II (CDAII) is a DNA methyltransferase inhibitor isolated from healthy human urine. In the present study, the antitumor activity of CDAII on human multiple myeloma (MM) cell lines via the mitochondrial pathway was first revealed. The human MM cell lines were exposed to CDAII. Cytotoxicity, caspase activation, apoptosis and the effects on the mitochondrial pathway were assessed. CDAâ ¡ was capable of decreasing the depolarized mitochondrial membranes and activating caspase3 and 9 and poly (ADPribose) polymerase in MM cells treated with CDAII. CDAII induced caspasedependent cell death accompanied by a significant decrease in X-linked inhibitor of apoptosis protein (XIAP), survivin and Mcl1 levels. The caspase3 inhibitor, ZDEVDFMK, inhibited CDAIIinduced apoptosis. CDAII potently increased the Bax levels, decreased the Bcl2/Bax ratio and decreased the expression of the downstream targets of NFκB. In conclusion, the results of the present study demonstrated that CDAII treatment leads to the inhibition of p65 nuclear localization and potently induces caspasedependent apoptosis in MM cells mediated through the mitochondrial pathway at low nanomolar concentrations. These results indicate that CDAII is a novel inhibitor of NFκB activity, with notable antimyeloma efficacy. This study provides a rationale for the clinical investigation of CDAâ ¡ in human MM.
Assuntos
Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Mitocôndrias/efeitos dos fármacos , Mieloma Múltiplo/patologia , Peptídeos/farmacologia , Fenilacetatos/farmacologia , Antineoplásicos/isolamento & purificação , Antineoplásicos/urina , Caspase 3/química , Caspase 3/metabolismo , Caspase 9/metabolismo , Inibidores de Caspase/farmacologia , Linhagem Celular Tumoral , Humanos , Interleucina-6/metabolismo , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Mitocôndrias/metabolismo , Mieloma Múltiplo/metabolismo , Proteína de Sequência 1 de Leucemia de Células Mieloides/metabolismo , NF-kappa B/antagonistas & inibidores , NF-kappa B/metabolismo , Oligopeptídeos/farmacologia , Peptídeos/isolamento & purificação , Peptídeos/urina , Fenilacetatos/isolamento & purificação , Fenilacetatos/urina , Poli(ADP-Ribose) Polimerases/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Fator de Transcrição RelA/metabolismo , Proteínas Inibidoras de Apoptose Ligadas ao Cromossomo X/metabolismo , Proteína X Associada a bcl-2/metabolismoRESUMO
SCOPE: Tea polyphenols are metabolized by the colonic microflora yielding phenolic metabolites, which may contribute to the health benefits of tea. We determined the serum and urine concentrations of phenolic acids, hippuric acid, and polyhydroxyphenyl-γ-valerolactones during green tea (GT) and black tea (BT) administration. The effects of (-)-epigallocatechin gallate (EGCG) and 3,4-dihydroxyphenylacetic acid (3,4-DHPAA) alone and in combination on bioavailability, intracellular metabolism, and antiproliferative activity were determined in HCT-116 colon cancer cells. METHODS AND RESULTS: The concentration of phenolic metabolites was quantified by HPLC with electrochemical detection and MS. Urine concentrations of 4-hydroxyphenylacetic acid (4-HPAA), 3-hydroxyphenylacetic acid (3-HPAA), and polyhydroxy-γ-valerolactones were increased significantly in men drinking GT compared to control. Urine concentration of 3-O-methylgallic acid (3OMGA) was significantly increased in men drinking BT compared to control. Serum 3,4-DHPAA was significantly increased after consumption of GT and BT and 4-HPAA after GT consumption. In vitro treatment of HCT-116 colon cancer cells with 3,4-DHPAA and EGCG exhibited an additive antiproliferative effect, while methylation of 3,4-DHPAA was significantly decreased. 3OMGA exhibited the strongest antiproliferative activity among the phenolic acids. CONCLUSION: The consumption of both, GT and BT, was associated with a significant increase in urinary and serum phenolic acids.
Assuntos
Anticarcinógenos/farmacologia , Neoplasias do Colo/prevenção & controle , Fenilacetatos/sangue , Fenilacetatos/urina , Chá/química , Ácido 3,4-Di-Hidroxifenilacético/farmacocinética , Ácido 3,4-Di-Hidroxifenilacético/farmacologia , Idoso , Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia , Camellia sinensis/química , Catequina/análogos & derivados , Catequina/farmacocinética , Catequina/farmacologia , Proliferação de Células/efeitos dos fármacos , Cromatografia Líquida de Alta Pressão , Ácido Gálico/análogos & derivados , Ácido Gálico/sangue , Ácido Gálico/urina , Células HCT116/efeitos dos fármacos , Hipuratos/sangue , Hipuratos/urina , Humanos , Hidroxibenzoatos/sangue , Hidroxibenzoatos/urina , Lactonas/urina , Masculino , Pessoa de Meia-Idade , Neoplasias da Próstata/complicações , Neoplasias da Próstata/dietoterapiaRESUMO
A convenient and reliable gas chromatographic method was developed for the simultaneous determination of six aromatic acid metabolites of styrene and styrene-oxide in rat urine; i.e., benzoic (BA), phenylacetic (PAA), mandelic (MA), phenylglyoxylic (PGA), hippuric (HA) and phenylaceturic (PAUA) acids. The method involves a one-pot esterification-extraction procedure, performed directly on urine without prior treatment. Analyses were performed on a RTX-1701 capillary column and the recovered isopropyl esters derivatives were detected by flame ionization detection. The analytical method was validated for selectivity, linearity, detection and quantification limits, recovery and intra-day and inter-day precisions. Calibration curves showed linearity in the range of 8-800 mg/L, except for HA and PAUA (40-800 mg/L). Limits of detection were between 0.2 (PPA) and 7.0 (PAUA) mg/L. The intra-day precisions determined at three concentrations levels were less than 5% for BA, PAA, MA and PGA and 9% for HA and PAUA, respectively. The corresponding mean inter-day precisions for these two groups were 8 and 16%, respectively. The method was successfully applied to quantitatively analyze styrene, styrene-oxide, ethylbenzene and toluene metabolites in urine samples from rats exposed by inhalation to these compounds at levels close to the occupational threshold limit values. Provided that this method can be transposed to human urine, it could have applications as part of biological monitoring for workers exposed to styrene or related compounds.
Assuntos
Ácidos Carbocíclicos/urina , Compostos de Epóxi/urina , Estireno/urina , Administração por Inalação , Animais , Ácido Benzoico/urina , Compostos de Epóxi/administração & dosagem , Compostos de Epóxi/farmacocinética , Ionização de Chama/métodos , Glioxilatos/urina , Hipuratos/urina , Exposição por Inalação , Limite de Detecção , Masculino , Ácidos Mandélicos/urina , Fenilacetatos/urina , Ratos , Ratos Endogâmicos F344 , Ratos Sprague-Dawley , Reprodutibilidade dos Testes , Estireno/administração & dosagem , Estireno/farmacocinética , Urinálise/métodosRESUMO
Red wine and grape polyphenols are considered to promote cardiovascular health and are involved in multiple biological functions. Their overall impact on the human metabolome is not known. Therefore, exogenous and endogenous metabolic effects were determined in fasting plasma and 24 h urine from healthy male adults consuming a mix of red wine and grape juice extracts (WGM) for 4 days in a placebo-controlled, crossover study. Syringic acid, 3-hydroxyhippuric acid, pyrogallol, 3-hydroxyphenylacetic acid, and 3-hydroxyphenylpropionic acid were confirmed as the strongest urinary markers of WGM intake. Overall, WGM had a mild impact on the endogenous metabolism. Most noticeable were changes in several amino acids deriving from tyrosine and tryptophan. Reductions in the microbial metabolites p-cresol sulfate and 3-indoxylsulfuric acid and increases in indole-3-lactic acid and nicotinic acid were observed in urine. In plasma, tyrosine was reduced. The results suggest that short-term intake of WGM altered microbial protein fermentation and/or amino acid metabolism.
Assuntos
Frutas/química , Metaboloma/efeitos dos fármacos , Extratos Vegetais/administração & dosagem , Polifenóis/administração & dosagem , Vitis/química , Vinho , Adolescente , Adulto , Idoso , Estudos Cross-Over , Ácido Gálico/análogos & derivados , Ácido Gálico/urina , Hipuratos/urina , Humanos , Masculino , Pessoa de Meia-Idade , Fenóis , Fenilacetatos/urina , Placebos , Propionatos/urina , Pirogalol/urina , Tirosina/sangueRESUMO
MOTIVATION: For the early detection of cancer, highly sensitive and specific biomarkers are needed. Particularly, biomarkers in bio-fluids are relatively more useful because those can be used for non-biopsy tests. Although the altered metabolic activities of cancer cells have been observed in many studies, little is known about metabolic biomarkers for cancer screening. In this study, a systematic method is proposed for identifying metabolic biomarkers in urine samples by selecting candidate biomarkers from altered genome-wide gene expression signatures of cancer cells. Biomarkers identified by the present study have increased coherence and robustness because the significances of biomarkers are validated in both gene expression profiles and metabolic profiles. RESULTS: The proposed method was applied to the gene expression profiles and urine samples of 50 breast cancer patients and 50 normal persons. Nine altered metabolic pathways were identified from the breast cancer gene expression signatures. Among these altered metabolic pathways, four metabolic biomarkers (Homovanillate, 4-hydroxyphenylacetate, 5-hydroxyindoleacetate and urea) were identified to be different in cancer and normal subjects (p <0.05). In the case of the predictive performance, the identified biomarkers achieved area under the ROC curve values of 0.75, 0.79 and 0.79, according to a linear discriminate analysis, a random forest classifier and on a support vector machine, respectively. Finally, biomarkers which showed consistent significance in pathways' gene expression as well as urine samples were identified. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Assuntos
Biomarcadores Tumorais/urina , Neoplasias da Mama/genética , Perfilação da Expressão Gênica/métodos , Metabolômica/métodos , Proteômica/métodos , Biomarcadores Tumorais/metabolismo , Neoplasias da Mama/metabolismo , Neoplasias da Mama/patologia , Feminino , Regulação Neoplásica da Expressão Gênica , Ácido Homovanílico/metabolismo , Ácido Homovanílico/urina , Humanos , Ácido Hidroxi-Indolacético/metabolismo , Ácido Hidroxi-Indolacético/urina , Fenilacetatos/metabolismo , Fenilacetatos/urina , Curva ROC , Ureia/metabolismo , Ureia/urinaRESUMO
Flavonoids, a subclass of polyphenols, are major constituents of many plant-based foods and beverages, including tea, wine and chocolate. Epidemiological studies have shown that a flavonoid-rich diet is associated with reduced risk of cardiovascular diseases. The majority of the flavonoids survive intact until they reach the colon where they are then extensively metabolized into smaller fragments. Here, we describe the development of GC-MS-based methods for the profiling of phenolic microbial fermentation products in urine, plasma, and fecal water. Furthermore, the methods are applicable for profiling products obtained from in vitro batch culture fermentation models. The methods incorporate enzymatic deconjugation, liquid-liquid extraction, derivatization, and subsequent analysis by GC-MS. At the level of individual compounds, the methods gave recoveries better than 80% with inter-day precision being better than 20%, depending on the matrix. Limits of detection were below 0.1 microg/ml for most phenolic acids. The newly developed methods were successfully applied to samples from human and in-vitro intervention trials, studying the metabolic impact of flavonoid intake. In conclusion, the methods presented are robust and generally applicable to diverse biological fluids. Its profiling character is useful to investigate on a large scale the gut microbiome-mediated bioavailability of flavonoids.
Assuntos
Biologia Computacional/métodos , Fermentação/fisiologia , Flavonoides/metabolismo , Cromatografia Gasosa-Espectrometria de Massas/métodos , Metabolismo , Fenóis/metabolismo , Colo/microbiologia , Dieta , Fezes/química , Flavonoides/sangue , Flavonoides/urina , Humanos , Fenóis/sangue , Fenóis/urina , Fenilacetatos/sangue , Fenilacetatos/urina , Polifenóis , Reprodutibilidade dos Testes , IncertezaAssuntos
Ceratodermia Palmar e Plantar/etiologia , Tirosinemias/complicações , Adulto , Biomarcadores/sangue , Biomarcadores/urina , Humanos , Ceratodermia Palmar e Plantar/diagnóstico , Ceratodermia Palmar e Plantar/metabolismo , Masculino , Fenilacetatos/sangue , Fenilacetatos/urina , Fenilpropionatos/sangue , Fenilpropionatos/urina , Ácidos Fenilpirúvicos/sangue , Ácidos Fenilpirúvicos/urina , Tirosina/sangue , Tirosina/urina , Tirosinemias/diagnóstico , Tirosinemias/metabolismoRESUMO
OBJECTIVE: To determine the variability of coumarin 7- and 3-hydroxylation in a human population and to evaluate the evidence for the existence of genetic polymorphism in these pathways. 7-Hydroxylation of coumarin is considered to be a detoxication pathway, whilst 3-hydroxylation, which predominates in rats, leads to hepatotoxicity in the rat. Coumarin metabolic phenotypes could aid in refining the risk evaluation for humans of dietary and environmental exposure to coumarin and for the chronic use of coumarin in high doses as a drug to treat lymphoedema and certain cancers. METHODS: Healthy male and female Jordanian volunteers (n = 103) were administered 2 mg coumarin by mouth and collected their 0-8-h urines. These, together with pre-dose blank urines, were analysed by selected-ion monitoring gas chromatography mass spectrometry for their content of the coumarin metabolites 7-hydroxycoumarin (70HC) and 2-hydroxyphenylacetic acid (2OHPAA), the latter arising from the 3-hydroxylation pathway. RESULTS: After coumarin administration, excretion of both 70HC and 2OHPAA was highly variable. A coumarin metabolic ratio (2OHPAA/7OHC) was suggestive of polymorphism. At least one subject had a metabolic response similar to an individual known to be both phenotypically and genotypically (CYP2A6 gene) 7-hydroxylation-deficient. CONCLUSION: In the light of the finding of high variability and possible polymorphism in both the 7- and 3-hydroxylation of coumarin in a human population. we recommend a reappraisal of the risk evaluation of human exposure to coumarin, particularly in pharmaceutical doses.
Assuntos
Hidrocarboneto de Aril Hidroxilases , Cumarínicos/metabolismo , Sistema Enzimático do Citocromo P-450/genética , Sistema Enzimático do Citocromo P-450/metabolismo , Oxigenases de Função Mista/genética , Oxigenases de Função Mista/metabolismo , Adulto , Cumarínicos/efeitos adversos , Citocromo P-450 CYP2A6 , Feminino , Cromatografia Gasosa-Espectrometria de Massas , Variação Genética , Humanos , Hidroxilação , Jordânia , Masculino , Fenilacetatos/urina , Polimorfismo Genético , Umbeliferonas/urinaRESUMO
The urinary excretion of 2-hydroxyphenylacetic acid (2HPAA) was studied in human volunteers after oral and parenteral doses of coumarin. The presence of 2HPAA in the urine was confirmed by gas chromatography mass spectroscopy (GC MS). Mass spectra of reference material and samples are presented. The determination of 2HPAA was carried out by GC with flame-ionization detection. Prior to analysis samples were extracted into ethyl ether and the analytes were derivatized with trimethlyphenylammonium hydroxide. A calibration range from 0.3 to 150 micrograms ml-1 was established using 3-hydroxyphenyl acetic acid (3HPAA) as an internal standard. On average less than 10% of the coumarin administered were excreted into the urine in the form of 2HPAA.
Assuntos
Cromatografia Gasosa/métodos , Cumarínicos/administração & dosagem , Fenilacetatos/urina , Administração Oral , Interações Medicamentosas , Ionização de Chama , Humanos , Infusões ParenteraisRESUMO
Methods for the nuclear magnetic resonance and gas chromatographic analysis of the enantiomers of p-trifluoromethylmandelic acid (p-TFM) and Mosher's acid (alpha-methoxy-alpha-(trifluoromethyl)phenylacetic acid) present in rat urine samples are described. Gas chromartography was performed using cyclodextrin capillary columns with both compounds analysed following derivatisation with methanolic HCl. Nuclear magnetic resonance was performed directly on the untreated urine samples following addition of beta-cyclodextrin. The methods were suitable for the determination of the individual enantiomers of the analytes in urine. Analysis of the rat urine samples indicated that the p-TFM had undergone a unidirectional enantiomeric interconversion in vivo, while the enantiomers of Mosher's acid were excreted unchanged.
Assuntos
Ácidos Mandélicos/química , Fenilacetatos/química , Animais , Cromatografia Gasosa , Flúor , Espectroscopia de Ressonância Magnética , Masculino , Ácidos Mandélicos/urina , Fenilacetatos/urina , Ratos , EstereoisomerismoRESUMO
The flavonoid quercetin, or its metabolites, inhibit chemical carcinogenesis in rodents and may have a role in the prevention of human cancers. Quercetin exposure in human populations results from the dietary intake of various plant foods; high concentrations of quercetin are found in apples, onions, tea, and red wine. Determination of the relationship between dietary intake and cancer risk depends on the characterization of quercetin intake. The development and use of biomarkers for quercetin intake may provide a basis for the objective classification of this exposure. One possible biomarker is metabolic products of quercetin. We report the development of a high-performance liquid chromatography (HPLC)-based assay for quantitation of quercetin metabolites in human urine. The metabolites include 3,4-dihydroxyphenylacetic acid (homoprotocatechuic acid), metahydroxyphenylacetic acid, and 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid). The assay has only two major steps, ether extraction and HPLC analysis, and is suitable for analysis of large sample numbers. Analytical characteristics of the assay include a sensitivity of less than 1 microgram, precision with coefficients of variation < 10%, and metabolite recoveries > 90%. The mean concentrations of 3,4-dihydroxyphenylacetic acid, metahydroxyphenylacetic acid, and homovanillic acid in two human urine samples are approximately 0.7, 4.8, and 2.8 micrograms/ml, respectively. The identification of each metabolite is confirmed by HPLC, UV absorbance scans, and gas chromatography-mass spectrometry analysis. These results verify the occurrence of quercetin metabolites in human urine and the feasibility of quercetin metabolite quantitation, by the assay described herein, for epidemiological studies. Development of the analytical procedure is an essential first step for validation of the metabolites as biomarkers of quercetin intake.
Assuntos
Quercetina/urina , Ácido 3,4-Di-Hidroxifenilacético/urina , Adulto , Anticarcinógenos/farmacologia , Biomarcadores/urina , Cromatografia Líquida de Alta Pressão , Dieta , Métodos Epidemiológicos , Estudos de Viabilidade , Flavonoides/metabolismo , Flavonoides/urina , Flavonóis , Cromatografia Gasosa-Espectrometria de Massas , Ácido Homovanílico/urina , Humanos , Masculino , Neoplasias/prevenção & controle , Fenilacetatos/urina , Quercetina/administração & dosagem , Quercetina/metabolismo , Quercetina/farmacologia , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Espectrofotometria UltravioletaRESUMO
Se determinó la concentración de serotonina plaquetaria (5-Hidroxitriptamina Plaquetaria 5HT-P) en 31 pacientes depresivos y en 29 casos control. Los pacientes depresivos fueran seleccionados de acuerdo al diagnóstico clínico y a los valores de feniletilamina (FEA) y ácido fenilacético total (AFAT) urinarios ya que consideramos que la disminución de estos dos parámetros es casi una constante en los procesos depresivos. De los 29 controles estudiados se seleccionaron 23 en los que los valores de FEA y AFAT fueron normales de acuerdo con publicaciones anteriores. El rango de valores de 5HT-P en este grupo fue de 527-900 ng/10 9 plaquetas plaq. con una media de 698+/-125 ng/10 9 plaq. En cuanto a los pacientes depresivos, se observaron 2 perfiles distintos. 19 presentaron valores de 5HT-P menores a los de los controles: 157-513 ng/10 9 plaq. con una media de 407+/-102, mientras que en los 13 restantes los valores fueron similares a los del grupo control: 552-780 ng/10 9 plaq. Considerando a las plaquetas como modelo de terminaciones nerviosas, cabe esperar, en ambos grupos una respuesta diferente al tratamiento con antidepresivos inhibidores de la recaptación de la serotonina, tema de estudio que hemos iniciado.
Assuntos
Humanos , Transtorno Depressivo/metabolismo , Serotonina/sangue , Fenetilaminas/urina , Fenilacetatos/urinaRESUMO
Phenylacetate, an inducer of tumor cytostasis and differentiation, shows promise as a relatively nontoxic antineoplastic agent. Phenylacetate, however, has an unpleasant odor that might limit patient acceptability. Phenylbutyrate, an odorless compound that also has activity in tumor models, is known to undergo rapid conversion to phenylacetate by beta-oxidation in vivo. This phase I study examined the pharmacokinetics of phenylbutyrate and characterized the disposition of the two metabolites, phenylacetate and phenylacetylglutamine. Fourteen patients with cancer (aged 51.8 +/- 13.8 years) received a 30-minute infusion of phenylbutyrate at 3 dose levels (600, 1200, and 2000 mg/m2). Serial blood samples and 24-hour urine collections were obtained. Samples were assayed by high-performance liquid chromatography. A model to simultaneously describe the pharmacokinetics of all three compounds was developed using ADAPT II. Data were modeled as molar equivalents. The model fit the data well as shown by mean (+/- SD) coefficients of determination (r2) for phenylbutyrate, phenylacetate, and phenylacetylglutamine, which were 0.96 +/- 0.07, 0.88 +/- 0.10, and 0.92 +/- 0.06, respectively. The intrapatient coefficient of variation percentage (CV%) around the parameter estimates were small (range 7.2-33.5%). Phenylbutyrate achieved peak concentrations in the range of in vitro tumor activity (500-2000 mumol/L) and exhibited saturable elimination (Km = 34.1 +/- 18.1 micrograms/mL and Vmax = 18.1 +/- 18 mg/h/kg). Metabolism was rapid; the times to maximum concentration for phenylacetate and phenylacetylglutamine were 1 and 2 hours, respectively. The conversion of phenylbutyrate to phenylacetate was extensive (80 +/- 12.6%), but serum concentrations of phenylacetate were low owing to rapid, subsequent conversion to phenylacetylglutamine.(ABSTRACT TRUNCATED AT 250 WORDS)